These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Management of infected stone disease with hydroxyurea: a five year follow-up.
    Author: Smith MJ.
    Journal: Proc Eur Dial Transplant Assoc; 1983; 20():466-8. PubMed ID: 6657670.
    Abstract:
    Hydroxyurea in a morning dose of 500 mg along with Macrodantin, 100 mg, has been used for more than five years as an adjunct to the management of retained struvite stones. Mild reversible toxicity occurs in 10 per cent. Urine sterility can be achieved in ninety per cent and no growth of the retained stone occurs.
    [Abstract] [Full Text] [Related] [New Search]